Cargando…
SPINK1 as a plasma marker for tumor hypoxia and a therapeutic target for radiosensitization
Hypoxia is associated with tumor radioresistance; therefore, a predictive marker for tumor hypoxia and a rational target to overcome it have been sought to realize personalized radiotherapy. Here, we show that serine protease inhibitor Kazal type I (SPINK1) meets these 2 criteria. SPINK1 expression...
Autores principales: | Suwa, Tatsuya, Kobayashi, Minoru, Shirai, Yukari, Nam, Jin-Min, Tabuchi, Yoshiaki, Takeda, Norihiko, Akamatsu, Shusuke, Ogawa, Osamu, Mizowaki, Takashi, Hammond, Ester M., Harada, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663551/ https://www.ncbi.nlm.nih.gov/pubmed/34747365 http://dx.doi.org/10.1172/jci.insight.148135 |
Ejemplares similares
-
An Overview of the Recent Development of Anticancer Agents Targeting the HIF-1 Transcription Factor
por: Shirai, Yukari, et al.
Publicado: (2021) -
Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation
por: Aizawa, Rihito, et al.
Publicado: (2019) -
Tumor microenvironment and radioresistance
por: Suwa, Tatsuya, et al.
Publicado: (2021) -
UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization
por: Nakashima, Ryota, et al.
Publicado: (2017) -
Role of Intrapancreatic SPINK1/Spink3 Expression in the Development of Pancreatitis
por: Ohmuraya, Masaki, et al.
Publicado: (2012)